I. Fu
- Analytical Chemistry top 5%
- Analytical Methods in Pharmaceuticals 3
- Spectroscopy top 5%
- Analytical Chemistry and Chromatography 3
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy 4
- Food Science top 10%
-
- HIV/AIDS drug development and treatment 2
-
- Pharmacological Effects and Assays 2
-
- Cytomegalovirus and herpesvirus research 1
-
- Microfluidic and Capillary Electrophoresis Applications 1
-
- T-cell and Retrovirus Studies 1
- Co-authors
- Eric WoolfB.K. MatuszewskiMark J. RoseYang XuLihong DuM.L. ConstanzerDonald G. MussonC.M. Chavez-Eng
- Journals
- Journal of Chromatography B (3 papers)Journal of Pharmaceutical and Biomedical Analysis (2 papers)Clinical Chemistry (1 paper)
- Partner nations
- United StatesUnited KingdomDenmark
In The Last Decade
I. Fu
12 papers receiving 365 citations
Peers
Comparison fields: 5 of 75
- Analytical Chemistry 123
- Spectroscopy 163
- Pharmacology 109
- Food Science 88
- Toxicology 15
Countries citing papers authored by I. Fu
This map shows the geographic impact of I. Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Fu more than expected).
Fields of papers citing papers by I. Fu
This network shows the impact of papers produced by I. Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Fu. The network helps show where I. Fu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside I. Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Abstract #3604: A phase I single-rising dose study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of an oral akt inhibitor in healthy male volunteers | 2009 | 4 |
| 2 | 2008 | 25 | |
| 3 | 2007 | 19 | |
| 4 | 2005 | 31 | |
| 5 | 2004 | 25 | |
| 6 | 2004 | 39 | |
| 7 | 2002 | 1 | |
| 8 | 1999 | 50 | |
| 9 | 1999 | 2 | |
| 10 | 1998 | 178 | |
| 11 | 1993 | 1 | |
| 12 | 1991 | 6 |
About I. Fu
I. Fu is a scholar working on Transplantation, Analytical Chemistry and Pharmacology, having authored 12 papers that have together received 381 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Analytical Chemistry and Chromatography (3 papers), Analytical Methods in Pharmaceuticals (3 papers), HIV/AIDS drug development and treatment (2 papers), Pharmacological Effects and Assays (2 papers), Cytomegalovirus and herpesvirus research (1 paper), Microfluidic and Capillary Electrophoresis Applications (1 paper) and T-cell and Retrovirus Studies (1 paper). The work is most often cited by research in Analytical Chemistry (123 citations), Spectroscopy (163 citations) and Pharmacology (109 citations). I. Fu has collaborated with scholars based in United States, United Kingdom and Denmark. Frequent co-authors include Eric Woolf, B.K. Matuszewski, Mark J. Rose, Yang Xu, Lihong Du, M.L. Constanzer, Donald G. Musson, C.M. Chavez-Eng, Philippe Danjou and Nancy Agrawal. Their work appears in journals such as Journal of Chromatography B, Journal of Pharmaceutical and Biomedical Analysis, Clinical Chemistry, British Journal of Clinical Pharmacology and Journal of Liquid Chromatography & Related Technologies.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.